C
Chirality Biosciences develops proprietary chiral separation technology to produce purer active pharmaceutical ingredients (APIs). This advanced manufacturing process reduces drug side effects and minimizes waste compared to traditional methods like HPLC. The company enables faster paths to market for safer therapeutics while maintaining FDA compliance.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Chirality Biosciences develops proprietary chiral separation technology to produce purer active pharmaceutical ingredients (APIs). This advanced manufacturing process reduces drug side effects and minimizes waste compared to traditional methods like HPLC. The company enables faster paths to market for safer therapeutics while maintaining FDA compliance.